Research Article
Bioactive Components and Potential Mechanism Prediction of Kui Jie Kang against Ulcerative Colitis via Systematic Pharmacology and UPLC-QE-MS Analysis
Table 2
Topological parameters of target nodes for KJK treatment of UC.
| name | DC | BC | CC | LAC |
| STAT3 | 77 | 0.045274 | 0.58409786 | 24.28571429 | TP53 | 77 | 0.10804017 | 0.58950617 | 19.27272727 | AKT1 | 72 | 0.05648135 | 0.57357357 | 20.66666667 | TNF | 69 | 0.04957359 | 0.56508876 | 20.23188406 | IL6 | 67 | 0.03643073 | 0.55847953 | 21.25373134 | MAPK3 | 63 | 0.04141007 | 0.56176471 | 20.38095238 | JUN | 58 | 0.022095 | 0.55202312 | 21.68965517 | EGFR | 58 | 0.04308535 | 0.54885057 | 20.4137931 | HSP90AA1 | 57 | 0.02596477 | 0.53501401 | 17.89473684 | VEGFA | 54 | 0.01922315 | 0.53954802 | 20.59259259 | IL1B | 54 | 0.02528887 | 0.52908587 | 18.33333333 | MAPK1 | 52 | 0.02487655 | 0.53501401 | 16.88461538 | CASP3 | 49 | 0.01588638 | 0.51761518 | 18.16326531 | MYC | 46 | 0.01799492 | 0.51069519 | 18.91304348 | ESR1 | 45 | 0.03593579 | 0.52043597 | 16.97777778 |
|
|